R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma

NCT00135499 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

138

Enrollment

OTHER

Sponsor class

Stopped Recruitment too low

Conditions

Lymphoma, Large-Cell, Diffuse

Interventions

DRUG: Rituximab
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Vindesine
DRUG: Bleomycin
DRUG: Prednisone
DRUG: Prednisone
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Vincristine

Sponsor

Lymphoma Study Association

Collaborators

[object Object]